Outlook For Blacks

Your recent articles on the status of black scientists, "Blacks Assail NIH's Plantation' Mentality [The Scientist, Nov. 26, 1990, page 1] and "NIH Inches Forward To Boost Ranks of Blacks Scientists" [Dec. 10, 1990, page 1], painted a bleak picture. NIH's extramural program has a number of special programs designed for minority institutions. NIH also has initiated new programs to help underrepresented minority scientists obtain training. However, recent statistics released by NIH indicate that

Written byJohn Fain
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NIH's extramural program has a number of special programs designed for minority institutions. NIH also has initiated new programs to help underrepresented minority scientists obtain training. However, recent statistics released by NIH indicate that applications by black scientists represented less than 0.6 percent of all applications for competing R01 grants.

The chances for funding of these applications were almost half that for white applicants in 1989 (8.9 percent for blacks and 18.6 percent for whites, based on new applications, and 21.4 percent versus 41.4 percent for renewal applications). The average priority score for applications by black scientists was 303 in 1989, while for white scientists was 246.

Equally disturbing was the fact that from 1985 to 1989 the number of R01 applications by black scientist that were approved decreased by 20 percent, while for white applicants the figure was unchanged. The gap between priority scores for black and white applicants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies